TRDA

Entrada Therapeutics Inc

NASDAQ · Biotechnology

$10.60

+0.53 (+5.26%)

Small-Cap Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Strong Buy

11 analysts

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +70.2% upside

Low Target $12.20

Average Target $18.04

High Target $27.27

Current Price $10.60

Current
$10.60

Target
$18.04

$12.20 $18.04 avg $27.27